Bisphosphonate use and breast cancer recurrence risk in the QUILT cohort

被引：0
|
作者：
Korde, L. A.
Doody, D. R.
Malone, K. E.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P5-15-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-15-03
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients
    Korde, Larissa A.
    Doody, David R.
    Hsu, Li
    Porter, Peggy L.
    Malone, Kathleen E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (02) : 165 - 173
  • [2] BISPHOSPHONATE USE AND RISK OF POSTMENOPAUSAL BREAST CANCER
    Aroner, Sarah
    Tamimi, Rulla
    Rosner, Bernard
    Hankinson, Susan
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S109 - S109
  • [3] Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
    Marilyn L. Kwan
    Jiaxiao M. Shi
    Laurel A. Habel
    Jun Song
    Joanie W-L Chung
    Chantal C. Avila
    Joanne E. Schottinger
    T. Craig Cheetham
    Suzanne W. Fletcher
    Reina Haque
    Breast Cancer Research and Treatment, 2016, 156 : 379 - 389
  • [4] Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
    Kwan, Marilyn L.
    Shi, Jiaxiao M.
    Habel, Laurel A.
    Song, Jun
    Chung, Joanie W-L
    Avila, Chantal C.
    Schottinger, Joanne E.
    Cheetham, T. Craig
    Fletcher, Suzanne W.
    Haque, Reina
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (02) : 379 - 389
  • [5] Oral Bisphosphonate Use Associated With a Decreased Risk of Breast Cancer
    不详
    CA-A CANCER JOURNAL FOR CLINICIANS, 2010, 60 (06) : 342 - 344
  • [6] Cancer: Bisphosphonate use and breast cancer
    Koch L.
    Nature Reviews Endocrinology, 2010, 6 (10) : 532 - 532
  • [7] Use of Glucocorticoids and Risk of Breast Cancer Recurrence
    Lietzen, Lone W.
    Cronin-Fenton, Deirdre P.
    Ahern, Thomas P.
    Sorensen, Henrik T.
    Christiansen, Peer
    Jensen, Anders B.
    Lash, Timothy L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 212 - 213
  • [8] Bisphosphonate Use After Estrogen Receptor-Positive Breast Cancer and Risk of Contralateral Breast Cancer
    Monsees, Genevieve M.
    Malone, Kathleen E.
    Tang, Mei-Tzu C.
    Newcomb, Polly A.
    Li, Christopher I.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (23) : 1752 - 1760
  • [9] Bisphosphonate use after primary breast cancer and risk of contralateral breast cancer using pharmacy data
    Kwan, M.
    Habel, L.
    Song, J.
    Weltzien, E.
    Chung, J.
    Sun, Y.
    Fletcher, S.
    Haque, R.
    CANCER RESEARCH, 2012, 72
  • [10] Oral bisphosphonate use and the risk of female breast, ovarian, and cervical cancer: a nationwide population-based cohort study
    Ye Seul Bae
    Jooyoung Chang
    Sang Min Park
    Archives of Osteoporosis, 2019, 14
12345